Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA)

BACKGROUND: Rheumatoid arthritis (RA) is one of the leading chronic inflammatory rheumatism. First-line therapy with synthetic disease-modifying antirheumatic drugs (sDMARD) is insufficiently effective in 40% of cases and these patients are treated with biotherapies. The increased use of these drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Freites-Núñez, Dalifer, Baillet, Athan, Rodriguez-Rodriguez, Luis, Nguyen, Minh Vu Chuong, Gonzalez, Isidoro, Pablos, Jose Luis, Balsa, Alejandro, Vazquez, Monica, Gaudin, Philippe, Fernandez-Gutierrez, Benjamín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456748/
https://www.ncbi.nlm.nih.gov/pubmed/32867830
http://dx.doi.org/10.1186/s13063-020-04683-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456748/
https://www.ncbi.nlm.nih.gov/pubmed/32867830
http://dx.doi.org/10.1186/s13063-020-04683-7

Ejemplares similares